Real-World Patterns of Basal Insulin Use with Other Diabetes Medications Among People with Type 2 Diabetes Between 2014 and 2020

INTRODUCTION: Basal insulin’s position in the type 2 diabetes (T2D) treatment paradigm has undergone significant revisions since the advent of diabetes medications such as glucagon-like peptide 1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT-2is), which offer cardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Schapiro, David, Juneja, Rattan, Huang, Ahong, Meeks, Alexandra, Liu, Dongju, Gelsey, Felicia T., Perez-Nieves, Magaly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241716/
https://www.ncbi.nlm.nih.gov/pubmed/37184630
http://dx.doi.org/10.1007/s13300-023-01414-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241716/
https://www.ncbi.nlm.nih.gov/pubmed/37184630
http://dx.doi.org/10.1007/s13300-023-01414-4

Ejemplares similares